NCT02682147View on ClinicalTrials.gov

Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 10, 2017

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Emphysema
Interventions
DRUG

Sildenafil

One dose of 20 mg Sildenafil will be given one hour before CT imaging.

Trial Locations (1)

52242

University of Iowa, Iowa City

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Eric A. Hoffman

OTHER